COMMUNIQUÉS West-GlobeNewswire

Vericel Reports Fourth Quarter and Year End 2017 Financial Results and Provides Full Year 2018 Financial Guidance

05/03/2018 - 13:30

Record Quarterly Revenues of $23.4 Million Represent a 41% Increase Over Fourth Quarter 2016 Positive Operating and Net Income Reported for the Fourth Quarter Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass [...]

Conatus Pharmaceuticals to Highlight Anticipated Clinical Data Readouts at Upcoming Investor Conferences

05/03/2018 - 13:30

SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- At three upcoming investor conferences in March, Conatus Pharmaceuticals Inc. (NASDAQ: CNAT ) President, Chief Executive Officer and co-founder, Steven J. Mento, Ph.D., and [...]

Actinium Announces $15.4 Million in Expected Gross Proceeds from Recently Expired Rights Offering

05/03/2018 - 13:30

NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company") announced today that the Company’s previously announced rights offering (“the Rights [...]

Zealand Pharma to present at the Cowen & Co. Health Care Conference, March 12, 2018 in Boston

05/03/2018 - 13:22

Press release - No. 06 / 2018 Zealand Pharma to present at the Cowen & Co. Health Care Conference, March 12, 2018 in Boston Copenhagen, March 5, 2018 - Britt Meelby Jensen, President and Chief Executive Officer (CEO [...]

Biohit Oyj - Managers' Transactions

05/03/2018 - 13:10

Biohit Oyj - Managers' Transactions, March 5, 2018 at 2:10 pm local time (EEST) Biohit Oyj has received the following notification. Biohit Oyj - Managers' Transactions ____________________________________________ Person [...]

Agios to Present at the Cowen 38th Annual Healthcare Conference Monday, March 12, 2018

05/03/2018 - 13:01

CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company [...]

SHIRE LAUNCHES MYPKFIT(TM) FOR ADVATE® [ANTIHEMOPHILIC FACTOR (RECOMBINANT)] IN THE U.S.

05/03/2018 - 13:00

SHIRE LAUNCHES MYPKFIT (TM) FOR ADVATE ® [ANTIHEMOPHILIC FACTOR (RECOMBINANT)] IN THE U.S. First and only FDA-cleared PK dosing software now available to help healthcare professionals create personalized treatment [...]

Horizon Discovery hosts Capital Markets Day today

05/03/2018 - 13:00

Horizon Discovery Group plc Horizon Discovery hosts Capital Markets Day today Cambridge, UK, 5 March 2018: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or "the Group"), a global leader in gene editing and gene [...]

BioDelivery Sciences to Present at the 30th Annual ROTH Conference

05/03/2018 - 13:00

RALEIGH, N.C., March 05, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that [...]

Lexington Cardiovascular Health Monitor Performing as Designed with First Clinical Patients

05/03/2018 - 09:05

VANCOUVER, British Columbia, March 05, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to provide an [...]

Medibio signs binding term sheet to acquire Vital Conversations

05/03/2018 - 09:00

Capitalizes on 3 years of partnership success in Corporate Health programs Appoints Peta Slocombe, founder of Australia’s Biggest Mental Health Check-In, to lead Medibio Corporate Health Strategic Business Unit [...]

Ossur Hf : Candidates to the Board of Directors

05/03/2018 - 08:00

Announcement no. 14/2018 Reykjavik, 5 March 2018 Candidates to the Board of Directors Enclosed details on the candidates to the Board of Directors of Össur hf., to be elected at the Company's Annual General Meeting held [...]

Santhera Reports Outcome of Exploratory Trial with Idebenone in PPMS Conducted at the NIH

05/03/2018 - 07:01

Pratteln, Switzerland, March 5, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that the exploratory Phase I/II clinical trial in primary progressive multiple sclerosis (PPMS) conducted as an investigator- [...]

Addex Secures Investor Commitment for CHF40 million Capital Increase Following Successful Completion of Book Building Process

05/03/2018 - 07:01

Geneva, Switzerland, 5 March 2018 - Addex Therapeutics (SIX: ADXN), the leading developer of oral allosteric modulators for neurological disorders, announced today that the Company has secured investor commitments for [...]

Immutep receives A$686,704 R&D Tax Incentive

05/03/2018 - 04:27

SYDNEY, Australia, March 04, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) (“Immutep” or the “Company”), is pleased to announce that it has received a A$686,704 cash rebate from the Australian [...]

Onconova Announces Presentation of Mechanism of Action Studies of Rigosertib Combination with Azacitidine at American Association for Cancer Research (AACR) Epigenetics Conference

04/03/2018 - 16:00

Effect of rigosertib plus azacitidine treatment on epigenetic modulation in cancer cell-lines and patient derived bone marrow cells Study suggests potential novel clinical strategies to improve outcomes for patients [...]

New Data from Pivotal Phase 3 Study Investigating Lanadelumab as a Prophylactic Treatment for HAE to be Presented at 2018 AAAAI/WAO Joint Congress

03/03/2018 - 15:46

New Data from Pivotal Phase 3 Study Investigating Lanadelumab as a Prophylactic Treatment for Hereditary Angioedema to be Presented at 2018 AAAAI/WAO Joint Congress - Data from the largest prevention study in HAE [...]

Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

02/03/2018 - 22:30

BURLINGTON, Mass., March 02, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced a grant of inducement stock options to two new employees for an aggregate of 4,000 shares of common stock [...]

Molecular Templates Closes $10 Million Debt Facility with Perceptive Advisors

02/03/2018 - 22:30

AUSTIN, Texas, March 02, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM ) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new [...]